BrightSpring Health Services, Inc.

BTSG Healthcare Health Information Services

In the quarter to June 2026, revenue grew 23.1%, EPS grew 192.9%, free cash flow fell 39.6% and total debt fell 13.1%, each against the same quarter a year earlier.

60.87 1.49 −2.39%
Market cap
$12.3B
P/E
34.0×
Fwd P/E
37.6×
Dividend yield
—
F-score
7/9
Altman Z
3.35
Beneish M
−2.64
Dividend safety
n/a

Insider Decisions trades per month

Total sells 3,362.07
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — 5 — — 5 — — 1 —
Insider Ownership 18.19%

Capital & Financial Ratios $m

Market Cap 12,340.00
Revenue 14,371.60
Net Income 365.38
Free Cash Flow 402.35
Net Debt 1,653.65
Current Ratio 1.59 (at or above 1.5: strong)
Debt/Equity 1.08
P/E ratio 34.01
Fwd P/E 37.60 (above 35: high)
P/S ratio 0.87
P/B ratio 6.12 (above 6: high)
Past 5Y EPS Growth —
This Y EPS Growth 81.85% (at or above 15%: strong)
Next Y EPS Growth 26.85% (at or above 15%: strong)
Next Y revenue growth 19.01% (at or above 10%: strong)
Next 5Y EPS Growth 41.11% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 13 61 88 550
Receivables 882 903 990 1,139
Inventory 403 637 815 575
Other — 131 882 —
1,457 1,893 2,894 2,470
2023 2024 2025 Q'26
Payables 642 924 1,218 1,091
ST’ Debt 32 49 52 41
Other — 118 196 —
1,248 1,428 1,849 1,556

Compound Annual Growth %

10y 5y 3y
Sales — — 18.69%
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 35.44%

Revenue $m

Mar Jun Sep Dec Year
’26 3,614 3,873 — — —
’25 2,878 3,148 3,334 3,551 12,911
’24 2,286 2,438 2,601 2,747 10,072
’23 2,028 2,167 2,257 2,375 7,691
’22 — — — — 7,721
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 123 44 — — —
’25 102 49 108 232 490
’24 (79) (15) 27 91 24
’23 40 (25) 34 162 211
’22 — — — (5) (5)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 101 15 — — —
’25 84 25 92 194 395
’24 (101) (39) 7 75 (57)
’23 22 (46) 16 146 137
’22 — — — (75) (75)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.67 0.38 — — —
’25 0.14 0.13 0.26 0.35 0.87
’24 (0.26) 0.10 (0.04) 0.08 (0.09)
’23 (0.19) 0.02 (1.10) (0.06) (1.31)
’22 — — — — (0.46)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — — — — 7.85 15.26

Analyst estimates 2026–2028

Powerpack
High — — — — — — — — 20.25 38.42
People
People Employees — — — — — — 35,000 35,000 37,000 23,500
Revenue/emp, $m — — — — — 0.00 0.22 0.22 0.27 0.55
Income, $m
Income, $m Revenue — — — — — 6,698 7,721 7,691 10,072 12,911
Gross margin, % — — — — — 18.64 17.54 14.81 12.57 11.76
EBT — — — — — 69 (46) (214) (95) 138
EBT margin, % — — — — — 1.03 (0.59) (2.78) (0.95) 1.07
Net income — — — — — 51 (54) (157) (21) 189
Depreciation — — — — — 220 265 223 217 176
Per share, $
Per share, $ Revenue — — — — — 56.96 65.52 65.25 52.19 63.74
Earnings — — — — — 0.44 (0.46) (1.31) (0.09) 0.94
Cash flow — — — — — 2.30 (0.04) 1.79 0.12 2.42
Capex — — — — — (0.50) (0.59) (0.62) (0.42) (0.47)
Free cash flow — — — — — 1.79 (0.63) 1.16 (0.30) 1.95
Book value — — — — — 0.00 6.41 4.97 8.54 9.26
Shares, m — — — — — 118 118 118 193 203
Valuation, ×
Valuation, × P/E — — — — — 0.00 0.00 0.00 0.00 39.84
P/S — — — — — 0.15 0.15 0.15 0.33 0.59
P/B — — — — — 2.21 2.21 2.21 1.99 4.05
EV/Sales — — — — — 0.53 0.53 0.53 0.58 0.78
EV/FCF — — — — — 34.02 34.02 34.02 (102.26) 25.39
Cash, $m
Cash, $m Operating cash flow — — — — — 270 (5) 211 24 490
Capex — — — — — (59) (70) (74) (81) (95)
Free cash flow — — — — — 211 (75) 137 (57) 395
Balance, $m
Balance, $m Working capital — — — — — — 412 208 465 1,045
Total debt — — — — — — 3,415 3,387 2,617 2,522
Net debt — — — — — — 3,401 3,374 2,556 2,434
Shareholders’ equity — — — — — — 755 585 1,648 1,875
Returns, %
Returns, % ROA — — — — — 0.00 (1.98) (2.82) (0.32) 3.09
ROIC — — — — — 0.00 2.82 0.92 1.60 4.28
ROE — — — — — 0.00 0.00 (23.07) (1.62) 10.82
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

BrightSpring Health Services, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
VEEV Veeva Systems Inc. $50.7B 50.0× 26.9× +17.60% (above 0%: growing) +36.59% (above 0%: growing) −0.62% (below 0%: shrinking) 75.00% 29.64% Compare
TEM Tempus AI, Inc. $12.8B — (loss-making) — (loss-making) +21.56% (above 0%: growing) n/m −153.72% (below 0%: shrinking) 64.45% (19.85%) Compare
BTSG BrightSpring Health Services, Inc. $12.3B 34.0× 37.6× +23.05% (above 0%: growing) +192.86% (above 0%: growing) −39.62% (below 0%: shrinking) 12.72% 3.37%
TXG 10x Genomics $9.4B — (loss-making) — (loss-making) −12.65% (below 0%: shrinking) n/m −4.61% (below 0%: shrinking) 74.48% (12.95%) Compare
HNGE Hinge Health Inc. $8.5B 73.5× 39.4× +53.00% (above 0%: growing) n/m +441.14% (above 0%: growing) 86.44% 19.00% Compare
HQY HealthEquity, Inc. $7.7B 33.0× 30.2× +7.64% (above 0%: growing) +14.49% (above 0%: growing) −3.44% (below 0%: shrinking) 73.55% 28.14% Compare
DOCS Doximity, Inc. $5.6B 34.8× 26.2× +7.34% (above 0%: growing) −53.57% (below 0%: shrinking) −34.14% (below 0%: shrinking) 84.87% 21.48% Compare
WAY Waystar Holding Corp. $5.4B 38.0× 22.4× +18.11% (above 0%: growing) +10.53% (above 0%: growing) −52.42% (below 0%: shrinking) 69.44% 23.79% Compare
HTFL Heartflow, Inc. $4.4B — (loss-making) — (loss-making) +47.57% (above 0%: growing) n/m +62.62% (above 0%: growing) 83.00% (27.93%) Compare
Median of peers $8.1B 38.0× 26.9× +17.86% +12.51% −4.02% 74.74% 20.24%

All 51 Health Information Services stocks →

BrightSpring Health Services, Inc. (BTSG) key facts

  • BrightSpring Health Services, Inc. (BTSG) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
  • Net income was $189.1 million, or $0.94 per share (basic), a net margin of 1.48%.
  • As of October 16, 2026, BTSG traded at $60.87, a market capitalization of $12.3 billion.
  • At that price the stock trades at 34.0× trailing-twelve-month earnings and 0.9× sales.
  • Return on equity was 10.8% and debt-to-equity 1.08.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.35 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

BrightSpring Health Services, Inc. (BTSG) Latest News

stockrow.com/BTSG · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com